[HTML][HTML] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European journal of …, 2017 - Elsevier
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
[HTML][HTML] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European Journal of …, 2017 - ejcancer.com
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
[PDF][PDF] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - … Journal of Cancer, 2017 - openaccessrepository.it
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).
MJ Duffy, N Harbeck, M Nap, R Molina… - European Journal of …, 2017 - europepmc.org
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
[引用][C] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European Journal of …, 2017 - cir.nii.ac.jp
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on
Tumor Markers (EGTM) | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Tumor Markers (EGTM) | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[PDF][PDF] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European Journal of …, 2017 - researchgate.net
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap… - … journal of cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap… - … Journal of Cancer, 2017 - epub.ub.uni-muenchen.de
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
[PDF][PDF] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European Journal of …, 2017 - cyberleninka.org
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
[PDF][PDF] Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
MJ Duffy, N Harbeck, M Nap, R Molina… - European Journal of …, 2017 - academia.edu
Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …